Dynavax Technologies Corporation
DVAX
$10.31
-$0.34-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.85% | -27.85% | -48.10% | -66.24% | -70.11% |
| Total Other Revenue | -53.57% | -26.45% | 35.12% | 70.19% | 110.10% |
| Total Revenue | 19.36% | -27.79% | -45.65% | -63.98% | -67.86% |
| Cost of Revenue | 5.64% | -19.98% | -42.27% | -58.57% | -60.73% |
| Gross Profit | 30.19% | -31.85% | -47.66% | -67.06% | -71.89% |
| SG&A Expenses | 4.89% | 11.33% | 13.09% | 10.82% | 27.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.18% | -2.76% | -16.94% | -32.47% | -32.12% |
| Operating Income | 102.93% | -107.13% | -108.59% | -107.71% | -109.07% |
| Income Before Tax | 806.57% | -61.31% | -83.52% | -96.70% | -101.48% |
| Income Tax Expenses | 75.42% | 152.02% | -28.29% | -177.89% | 76.90% |
| Earnings from Continuing Operations | 527.44% | -66.50% | -84.48% | -96.09% | -102.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 527.44% | -66.50% | -84.48% | -96.09% | -102.18% |
| EBIT | 102.93% | -107.13% | -108.59% | -107.71% | -109.07% |
| EBITDA | 121.14% | -101.79% | -105.33% | -106.00% | -107.69% |
| EPS Basic | 510.39% | -67.40% | -84.76% | -96.12% | -102.20% |
| Normalized Basic EPS | 647.41% | -77.98% | -89.10% | -97.58% | -101.62% |
| EPS Diluted | 382.62% | -65.88% | -84.35% | -96.32% | -103.19% |
| Normalized Diluted EPS | 386.45% | -78.71% | -90.03% | -98.25% | -102.89% |
| Average Basic Shares Outstanding | 1.03% | 1.66% | 1.62% | 1.63% | 1.85% |
| Average Diluted Shares Outstanding | 4.40% | -2.26% | -1.92% | -1.94% | -5.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |